General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Application of hiPSC-derived Cardiosight®-S

Current preclinical drug development faces challenges in accurately predicting cardiac toxicity, particularly arrhythmia risk. To overcome the limitations inherent in 2D monolayer cultures, we developed and utilized hiPSC-derived COs, which provides a more physiologically relevant model of the human heart.hiPSC-CMs offer a promising alternative for the early detection of cardiac arrhythmia risks in drug development, while hiPSC-derived organoid models provide enhanced functionality and reliable disease modeling. By combining 2D hiPSC-CMs with organoid models, we could achieve a more comprehensive evaluation of investigational drugs.

APPW2025

Presentation Information

[2LS10-02]Application of hiPSC-derived Cardiosight®-S

Comment